Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ASCO
ASCO
Novartis bone marrow drug improves progression-free survival
Yahoo/Reuters
Mon, 06/2/14 - 10:04 am
Novartis
LBH589
Multiple Myeloma
ASCO
Clovis' Lung Cancer Bravado Falls Flat With New Diabetes Revelation
TheStreet.com
Mon, 06/2/14 - 09:44 am
Clovis Oncology
diabetes
CO-1686
AZD9291
lung cancer
ASCO
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Mon, 06/2/14 - 09:42 am
Yervoy
brain cancer
immunotherapy
Bristol-Myers Squibb
ASCO
nivolumab
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
Yahoo/Fly on the Wall
Mon, 06/2/14 - 09:40 am
AbbVie
ABT-199
GDC-0199
B-cell lymphoma
ASCO
AstraZeneca Cancer News Boosts Soriot’s $45 Billion Case
Bloomberg
Mon, 06/2/14 - 09:27 am
AstraZeneca
Pascal Soriot
ASCO
cancer
Pfizer
Drug flops from 2004 haunt AstraZeneca investors
Yahoo/Reuters
Tue, 05/20/14 - 09:47 am
AstraZeneca
ASCO
Exanta
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Bristol-Myers Squibb
Merck
Roche
ASCO
cancer
anti-PD-1 immunotherapy
[video]ASCO Abstracts: Bristol-Myers Squibb's and Merck's Immuno-Oncology Drugs
Motley Fool
Wed, 05/14/14 - 08:22 am
ASCO
Bristol-Myers Squibb
Merck
immuno-oncology
Cancer Doctors Plan to Compare Value of Expensive Drugs
Bloomberg
Wed, 04/16/14 - 05:17 pm
cancer
physicians
ASCO
Are pricey cancer drugs worth the cost? ASCO means to find out
Fierce Pharma
Wed, 03/26/14 - 12:40 pm
ASCO
drug pricing
Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
Seeking Alpha
Mon, 06/10/13 - 11:00 am
ASCO
Infinity Pharmaceuticals
Gilead
IPI-145
ASCO Stocks That Should Sizzle in the Future
Motley Fool
Mon, 06/10/13 - 10:12 am
ASCO
Merck
Clovis Oncology
Bristol-Myers Squibb
Celgene at ASCO: Ho-Hum, Ho-Hum, and Hmmm
Motley Fool
Wed, 06/5/13 - 12:24 pm
Celgene
ASCO
Pomalyst
Abraxane
Revlimid
Clovis Oncology Skyrockets After ASCO Presentations
Seeking Alpha
Tue, 06/4/13 - 12:28 pm
ASCO
Clovis Oncology
CO-1686
rucaparib
Analyst: Cancer Drugs Push Investors Into Pharma
Barron's
Tue, 06/4/13 - 10:00 am
cancer
ASCO
Merck
Bristol-Myers Squibb
Two Diversified Biotechs to Watch After Impressive ASCO Data
Motley Fool
Mon, 06/3/13 - 12:36 pm
ONYX Pharmaceuticals
Nexavar
tergenpumatucel-L
NewLink Genetics
ASCO
Merck jumps on melanoma treatment results
Marketwatch
Mon, 06/3/13 - 11:26 am
Merck
melanoma
lambrolizumab
ASCO
Cancer Drug Shortages Force Doctors to Ration, Delay Treatment
Bloomberg
Mon, 06/3/13 - 10:59 am
drug shortages
ASCO
physicians
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
TheStreet.com
Mon, 06/3/13 - 10:20 am
nivolumab
Merck
melanoma
lambrolizumab
Bristol-Myers Squibb
ASCO
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »